Epivir (lamivudine) Tablets and Oral Solution
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
July 2016
WARNINGS AND PRECAUTIONS
Lower Virologic Suppression Rates and Increased Risk of Viral Resistance with Oral Solution
...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts